Tiotropium (Spiriva Respimat) will be the first long-acting anticholinergic for ASTHMA

Tiotropium (Spiriva Respimat) will be the first long-acting anticholinergic for ASTHMA. It won't just be for COPD anymore.

But don't expect to use it first-line for asthma.

Adding tiotropium to a medium-dose inhaled steroid may improve lung function similar to adding a long-acting beta-agonist (salmeterol, etc).

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals